{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:39:37Z","timestamp":1790023177024,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00011-024-01885-6","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T10:02:16Z","timestamp":1714125736000},"page":"1099-1106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule"],"prefix":"10.1007","volume":"73","author":[{"given":"G. P.","family":"Suchitha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex","family":"Devasahayam Arokia Balaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S. Keshava","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha","family":"Dagamajalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"1885_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1100\/tsw.2007.186","volume":"7","author":"M Romano","year":"2007","unstructured":"Romano M, Recchia I, Recchiuti A. Lipoxin receptors. Sci World J. 2007;7:1393\u2013412. https:\/\/doi.org\/10.1100\/tsw.2007.186.","journal-title":"Sci World J"},{"key":"1885_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.coph.2010.02.005","volume":"10","author":"A Ryan","year":"2010","unstructured":"Ryan A, Godson C. Lipoxins: regulators of resolution. Curr Opin Pharmacol. 2010;10:166\u201372. https:\/\/doi.org\/10.1016\/j.coph.2010.02.005.","journal-title":"Curr Opin Pharmacol"},{"key":"1885_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/0006-291x(84)91486-4","volume":"118","author":"CN Serhan","year":"1984","unstructured":"Serhan CN, Hamberg M, Samuelsson B. Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem Biophys Res Commun. 1984;118:943\u20139. https:\/\/doi.org\/10.1016\/0006-291x(84)91486-4.","journal-title":"Biochem Biophys Res Commun"},{"key":"1885_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-pharmtox-051921-085407","volume":"63","author":"C Godson","year":"2013","unstructured":"Godson C, Guiry P, Brennan E. Lipoxin mimetics and the resolution of inflammation. Annu Rev Pharmacol Toxicol. 2013;63:429\u201348. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051921-085407.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1885_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","volume":"73","author":"CN Serhan","year":"2005","unstructured":"Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids. 2005;73:141\u201362. https:\/\/doi.org\/10.1016\/j.plefa.2005.05.002.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1885_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1124\/pr.58.3.4","volume":"58","author":"N Chiang","year":"2006","unstructured":"Chiang N, Serhan CN, Dahlen SE, et al. The lipoxin receptor ALX: potent ligand-specific and stereoselectiveactions in vivo. Pharmacol Rev. 2006;58:463\u201387. https:\/\/doi.org\/10.1124\/pr.58.3.4.","journal-title":"Pharmacol Rev"},{"key":"1885_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejphar.2015.11.001","volume":"785","author":"MG Duvall","year":"2016","unstructured":"Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol. 2016;785:144\u201355. https:\/\/doi.org\/10.1016\/j.ejphar.2015.11.001.","journal-title":"Eur J Pharmacol"},{"key":"1885_CR8","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","volume":"20","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20:6008. https:\/\/doi.org\/10.3390\/ijms20236008.","journal-title":"Int J Mol Sci"},{"key":"1885_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acsptsci.9b00097","volume":"3","author":"T Fu","year":"2020","unstructured":"Fu T, Mohan M, Brennan EP, et al. Therapeutic potential of Lipoxin A4 in chronic inflammation: focus on cardiometabolic disease. ACS Pharmacol Transl Sci. 2020;3:43\u201355. https:\/\/doi.org\/10.1021\/acsptsci.9b00097.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1885_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/JIR.S90380","volume":"8","author":"JA Chandrasekharan","year":"2015","unstructured":"Chandrasekharan JA, Sharma-Walia N. Lipoxins: nature\u2019s way to resolve inflammation. J Inflamm Res. 2015;8:181\u201392. https:\/\/doi.org\/10.2147\/JIR.S90380.","journal-title":"J Inflamm Res"},{"key":"1885_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658840","volume":"12","author":"RI Jaen","year":"2021","unstructured":"Jaen RI, Sanchez-Garcia S, Fernandez-Velasco M, et al. Resolution-based therapies: the potential of lipoxins to treat human diseases. Front Immunol. 2021;12: 658840. https:\/\/doi.org\/10.3389\/fimmu.2021.658840.","journal-title":"Front Immunol"},{"key":"1885_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/eji.201343316","volume":"44","author":"S Ramon","year":"2014","unstructured":"Ramon S, Bancos S, Serhan CN, et al. Lipoxin A4 modulates adaptive immunity by decreasing memory B-cell responses via an ALX\/FPR2-dependent mechanism. Eur J Immunol. 2014;44:357\u201369. https:\/\/doi.org\/10.1002\/eji.201343316.","journal-title":"Eur J Immunol"},{"key":"1885_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2021.158940","volume":"1866","author":"D Andrews","year":"2021","unstructured":"Andrews D, Godson C. Lipoxins and synthetic lipoxin mimetics: therapeutic potential in renal diseases. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866: 158940. https:\/\/doi.org\/10.1016\/j.bbalip.2021.158940.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1885_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/cdd.2009.220","volume":"17","author":"P Prieto","year":"2010","unstructured":"Prieto P, Cuenca J, Trav\u00e9s PG, et al. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K\/Akt and the ERK\/Nrf-2 defense pathways. Cell Death Differ. 2010;17:1179\u201388. https:\/\/doi.org\/10.1038\/cdd.2009.220.","journal-title":"Cell Death Differ"},{"key":"1885_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3892\/etm.2020.8812","volume":"20","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, You H, Zhang A, et al. Lipoxin A4 attenuates uric acid-activated, NADPH oxidase-dependent oxidative stress by interfering with translocation of p47phox in human umbilical vein endothelial cells. Exp Ther Med. 2020;20:1682\u201392. https:\/\/doi.org\/10.3892\/etm.2020.8812.","journal-title":"Exp Ther Med"},{"key":"1885_CR16","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12031-015-0525-6","volume":"56","author":"L Wu","year":"2015","unstructured":"Wu L, Li HH, Wu Q, et al. Lipoxin A4 activates Nrf2 pathway and ameliorates cell damage in cultured cortical astrocytes exposed to oxygen-glucose deprivation\/reperfusion insults. J Mol Neurosci. 2015;56:848\u201357. https:\/\/doi.org\/10.1007\/s12031-015-0525-6.","journal-title":"J Mol Neurosci"},{"key":"1885_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cellsig.2019.05.002","volume":"60","author":"S Yang","year":"2019","unstructured":"Yang S, Zheng Y, Hou X. Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis. Cell Signal. 2019;60:146\u201353. https:\/\/doi.org\/10.1016\/j.cellsig.2019.05.002.","journal-title":"Cell Signal"},{"key":"1885_CR18","doi-asserted-by":"publisher","DOI":"10.5936\/csbj.201303018","volume":"6","author":"V Urbach","year":"2013","unstructured":"Urbach V, Higgins G, Buchanan P, et al. The role of Lipoxin A4 in cystic fibrosis lung disease. Comput Struct Biotechnol J. 2013;6: e201303018. https:\/\/doi.org\/10.5936\/csbj.201303018.","journal-title":"Comput Struct Biotechnol J"},{"key":"1885_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/781087","volume":"2015","author":"G Higgins","year":"2015","unstructured":"Higgins G, Ringholz F, Buchanan P, et al. Physiological impact of abnormal lipoxin A4 production on cystic fibrosis airway epithelium and therapeutic potential. Biomed Res Int. 2015;2015: 781087. https:\/\/doi.org\/10.1155\/2015\/781087.","journal-title":"Biomed Res Int"},{"key":"1885_CR20","doi-asserted-by":"publisher","first-page":"L1053","DOI":"10.1152\/ajplung.00368.2015","volume":"310","author":"G Higgins","year":"2016","unstructured":"Higgins G, Fustero Torre C, Tyrrell J, et al. Lipoxin A4 prevents tight junction disruption and delays the colonization of cystic fibrosis bronchial epithelial cells by Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol. 2016;310:L1053\u201361. https:\/\/doi.org\/10.1152\/ajplung.00368.2015.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1885_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1165\/rcmb.2012-0424OC","volume":"51","author":"G Higgins","year":"2014","unstructured":"Higgins G, Buchanan P, Perriere M, et al. Activation of P2RY11 and ATP release by Lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis. Am J Respir Cell Mol Biol. 2014;51:178\u201390. https:\/\/doi.org\/10.1165\/rcmb.2012-0424OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1885_CR22","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/gb-2010-11-1-r3","volume":"11","author":"K Kandasamy","year":"2010","unstructured":"Kandasamy K, Mohan SS, Raju R, et al. NetPath: a public resource of curated signal transduction pathways. Genome Biol. 2010;11:R3. https:\/\/doi.org\/10.1186\/gb-2010-11-1-r3.","journal-title":"Genome Biol"},{"issue":"21","key":"1885_CR23","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/bioinformatics\/btp453","volume":"25","author":"K Kandasamy","year":"2009","unstructured":"Kandasamy K, Keerthikumar S, Raju R, et al. PathBuilder\u2013open source software for annotating and developing pathway resources. Bioinformatics. 2009;25(21):2860\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btp453.","journal-title":"Bioinformatics"},{"key":"1885_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004085","volume":"11","author":"M Kutmon","year":"2015","unstructured":"Kutmon M, van Iersel MP, Bohler A, et al. PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput Biol. 2015;11: e1004085. https:\/\/doi.org\/10.1371\/journal.pcbi.1004085.","journal-title":"PLoS Comput Biol"},{"key":"1885_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5152\/eurasianjmed.2022.20030","volume":"54","author":"ZM Karaca","year":"2022","unstructured":"Karaca ZM, Kurtoglu EL, Gul M, et al. Influence of lipoxin-A4 treatment on cytokine, chemokine genes expression, and phenotypic distribution of lymphocyte subsets during experimental liver fibrosis. Eurasian J Med. 2022;54:27\u201335. https:\/\/doi.org\/10.5152\/eurasianjmed.2022.20030.","journal-title":"Eurasian J Med"},{"key":"1885_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113645","volume":"339","author":"QQ Li","year":"2021","unstructured":"Li QQ, Ding DH, Wang XY, et al. Lipoxin A4 regulates microglial M1\/M2 polarization after cerebral ischemia-reperfusion injury via the Notch signaling pathway. Exp Neurol. 2021;339: 113645. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113645.","journal-title":"Exp Neurol"},{"key":"1885_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1365-3083.2002.01149.x","volume":"56","author":"T Christophe","year":"2002","unstructured":"Christophe T, Karlsson A, Rabiet MJ, et al. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1\/LXA4R, is not affected by Lipoxin A4. Scand J Immunol. 2002;56:470\u20136. https:\/\/doi.org\/10.1046\/j.1365-3083.2002.01149.x.","journal-title":"Scand J Immunol"},{"key":"1885_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/STROKEAHA.115.011223","volume":"47","author":"Z Guo","year":"2016","unstructured":"Guo Z, Hu Q, Xu L, et al. Lipoxin A4 reduces inflammation through formyl peptide receptor 2\/p38 MAPK signaling pathway in subarachnoid hemorrhage rats. Stroke. 2016;47:490\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011223.","journal-title":"Stroke"},{"key":"1885_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2018.09.025","volume":"278","author":"J Mai","year":"2018","unstructured":"Mai J, Liu W, Fang Y, et al. The atheroprotective role of lipoxin A(4) prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway. Atherosclerosis. 2018;278:259\u201368. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.09.025.","journal-title":"Atherosclerosis"},{"key":"1885_CR30","first-page":"1850","volume":"21","author":"Y Shi","year":"2017","unstructured":"Shi Y, Pan H, Zhang HZ, et al. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-kappaB and PI3K\/Akt signaling pathway in mice. Eur Rev Med Pharmacol Sci. 2017;21:1850\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1885_CR31","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1096\/fj.12-208249","volume":"26","author":"E Borgeson","year":"2012","unstructured":"Borgeson E, McGillicuddy FC, Harford KA, et al. Lipoxin A4 attenuates adipose inflammation. FASEB J. 2012;26:4287\u201394. https:\/\/doi.org\/10.1096\/fj.12-208249.","journal-title":"FASEB J"},{"key":"1885_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuroscience.2019.03.038","volume":"408","author":"L Liu","year":"2019","unstructured":"Liu L, Zhang P, Zhang Z, et al. LXA4 ameliorates cerebrovascular endothelial dysfunction by reducing acute inflammation after subarachnoid hemorrhage in rats. Neuroscience. 2019;408:105\u201314. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.03.038.","journal-title":"Neuroscience"},{"key":"1885_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107095","volume":"89","author":"JJ Zhu","year":"2020","unstructured":"Zhu JJ, Yu BY, Fu CC, et al. LXA4 protects against hypoxic-ischemic damage in neonatal rats by reducing the inflammatory response via the IkappaB\/NF-kappaB pathway. Int Immunopharmacol. 2020;89: 107095. https:\/\/doi.org\/10.1016\/j.intimp.2020.107095.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1885_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000221379","volume":"84","author":"S Liu","year":"2009","unstructured":"Liu S, Wu P, Ye D, et al. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells. Pharmacology. 2009;84(1):17\u201323. https:\/\/doi.org\/10.1159\/000221379.","journal-title":"Pharmacology"},{"key":"1885_CR35","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.1038\/s41598-018-27194-7","volume":"8","author":"A Gaudin","year":"2018","unstructured":"Gaudin A, Tolar M, Peters OA. Lipoxin A(4) attenuates the inflammatory response in stem cells of the apical papilla via ALX\/FPR2. Sci Rep. 2018;8:8921. https:\/\/doi.org\/10.1038\/s41598-018-27194-7.","journal-title":"Sci Rep"},{"key":"1885_CR36","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.ajpath.2019.07.011","volume":"189","author":"SG Dakin","year":"2019","unstructured":"Dakin SG, Colas RA, Wheway K, et al. Proresolving mediators LXB4 and RvE1 regulate inflammation in stromal cells from patients with shoulder tendon tears. Am J Pathol. 2019;189:2258\u201368. https:\/\/doi.org\/10.1016\/j.ajpath.2019.07.011.","journal-title":"Am J Pathol"},{"key":"1885_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2197017","author":"W Ye","year":"2019","unstructured":"Ye W, Zheng C, Yu D, et al. Lipoxin A4 ameliorates acute pancreatitis-associated acute lung injury through the antioxidative and anti-inflammatory effects of the Nrf2 pathway. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/2197017.","journal-title":"Oxid Med Cell Longev"},{"key":"1885_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/00365521.2010.525715","volume":"46","author":"M Zhou","year":"2011","unstructured":"Zhou M, Chen B, Sun H, et al. The protective effects of Lipoxin A4 during the early phase of severe acute pancreatitis in rats. Scand J Gastroenterol. 2011;46:211\u20139. https:\/\/doi.org\/10.3109\/00365521.2010.525715.","journal-title":"Scand J Gastroenterol"},{"key":"1885_CR39","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1096\/fj.201900196R","volume":"33","author":"SG Dakin","year":"2019","unstructured":"Dakin SG, Colas RA, Newton J, et al. 15-Epi-LXA(4) and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture. FASEB J. 2019;33:8043\u201354. https:\/\/doi.org\/10.1096\/fj.201900196R.","journal-title":"FASEB J"},{"key":"1885_CR40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/mi.2014.116","volume":"8","author":"L Karra","year":"2015","unstructured":"Karra L, Haworth O, Priluck R, et al. Lipoxin B(4) promotes the resolution of allergic inflammation in the upper and lower airways of mice. Mucosal Immunol. 2015;8:852\u201362. https:\/\/doi.org\/10.1038\/mi.2014.116.","journal-title":"Mucosal Immunol"},{"key":"1885_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2018.02.039","volume":"198","author":"YP Guo","year":"2018","unstructured":"Guo YP, Jiang HK, Jiang H, et al. Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-kappaB and ERK\/p38 MAPK-dependent inflammation. Life Sci. 2018;198:112\u20138. https:\/\/doi.org\/10.1016\/j.lfs.2018.02.039.","journal-title":"Life Sci"},{"key":"1885_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.trsl.2015.02.009","volume":"166","author":"A Marginean","year":"2015","unstructured":"Marginean A, Sharma-Walia N. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi\u2019s sarcoma cells. Transl Res. 2015;166:111\u201333. https:\/\/doi.org\/10.1016\/j.trsl.2015.02.009.","journal-title":"Transl Res"},{"key":"1885_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jdermsci.2015.03.009","volume":"78","author":"F Hu","year":"2015","unstructured":"Hu F, Liu XX, Wang X, et al. Lipoxin A4 inhibits proliferation and inflammatory cytokine\/chemokine production of human epidermal keratinocytes associated with the ERK1\/2 and NF-kappaB pathways. J Dermatol Sci. 2015;78:181\u20138. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.03.009.","journal-title":"J Dermatol Sci"},{"key":"1885_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12031-012-9807-4","volume":"48","author":"L Wu","year":"2012","unstructured":"Wu L, Miao S, Zou LB, et al. Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia\/reperfusion injury. J Mol Neurosci. 2012;48:185\u2013200. https:\/\/doi.org\/10.1007\/s12031-012-9807-4.","journal-title":"J Mol Neurosci"},{"key":"1885_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9019404","author":"S Yu","year":"2019","unstructured":"Yu S, Xie J, Xiang Y, et al. Downregulation of TNF-alpha\/TNF-R1 signals by AT-Lipoxin A4 may be a significant mechanism of attenuation in SAP-associated lung injury. Mediators Inflamm. 2019. https:\/\/doi.org\/10.1155\/2019\/9019404.","journal-title":"Mediators Inflamm"},{"key":"1885_CR46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1073\/pnas.1109382109","volume":"109","author":"S Bozinovski","year":"2012","unstructured":"Bozinovski S, Uddin M, Vlahos R, et al. Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci USA. 2012;109:935\u201340. https:\/\/doi.org\/10.1073\/pnas.1109382109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1885_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1371\/journal.pone.0075543","volume":"24","author":"S Abdelmoaty","year":"2013","unstructured":"Abdelmoaty S, Wigerblad G, Bas DB, et al. Spinal actions of Lipoxin A4 and 17 (R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. PLoS ONE. 2013;24:8-e75543. https:\/\/doi.org\/10.1371\/journal.pone.0075543.","journal-title":"PLoS ONE"},{"key":"1885_CR48","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.biopha.2017.10.092","volume":"97","author":"T Lu","year":"2018","unstructured":"Lu T, Wu X, Wei N, et al. Lipoxin A4 protects against spinal cord injury via regulating Akt\/nuclear factor (erythroid-derived 2)-like 2\/heme oxygenase-1 signaling. Biomed Pharmacother. 2018;97:905\u201310. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.092.","journal-title":"Biomed Pharmacother"},{"key":"1885_CR49","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1179\/1743132813Y.0000000242","volume":"35","author":"L Wu","year":"2013","unstructured":"Wu L, Liu ZJ, Miao S, et al. Lipoxin A4 ameliorates cerebral ischaemia\/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2. Neurol Res. 2013;35:968\u201375. https:\/\/doi.org\/10.1179\/1743132813Y.0000000242.","journal-title":"Neurol Res"},{"key":"1885_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/1440-1681.13023","volume":"46","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qu M, Yang Q, et al. Lipoxin A4 ameliorates renal ischaemia-reperfusion-induced acute lung injury in rats. Clin Exp Pharmacol Physiol. 2019;46:65\u201374. https:\/\/doi.org\/10.1111\/1440-1681.13023.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1885_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3892\/mmr.2019.10821","volume":"21","author":"YY Luo","year":"2020","unstructured":"Luo YY, Wu SH, Lu HY, et al. Lipoxin A4 attenuates hyperoxia-induced lung epithelial cell injury via the upregulation of heme oxygenase-1 and inhibition of proinflammatory cytokines. Mol Med Rep. 2020;21:429\u201337. https:\/\/doi.org\/10.3892\/mmr.2019.10821.","journal-title":"Mol Med Rep"},{"key":"1885_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12931-019-1158-z","volume":"20","author":"JX Yang","year":"2019","unstructured":"Yang JX, Li M, Chen XO, et al. Lipoxin A(4) ameliorates lipopolysaccharide-induced lung injury through stimulating epithelial proliferation, reducing epithelial cell apoptosis and inhibits epithelial-mesenchymal transition. Respir Res. 2019;20:192. https:\/\/doi.org\/10.1186\/s12931-019-1158-z.","journal-title":"Respir Res"},{"issue":"8","key":"1885_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067120","volume":"2013","author":"XQ Chen","year":"2013","unstructured":"Chen XQ, Wu SH, Zhou Y, et al. Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia\/reoxygenation injury via p38 MAPK activation and Nrf2\/ARE complex. PLoS ONE. 2013;2013(8): e67120. https:\/\/doi.org\/10.1371\/journal.pone.0067120.","journal-title":"PLoS ONE"},{"key":"1885_CR54","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3892\/mmr.2017.6195","volume":"15","author":"SH Wu","year":"2017","unstructured":"Wu SH, Wang MJ, Lu J, et al. Signal transduction involved in lipoxin A4-induced protection of tubular epithelial cells against hypoxia\/reoxygenation injury. Mol Med Rep. 2017;15:1682\u201392. https:\/\/doi.org\/10.3892\/mmr.2017.6195.","journal-title":"Mol Med Rep"},{"key":"1885_CR55","first-page":"1139","volume":"9","author":"H Zong","year":"2017","unstructured":"Zong H, Li X, Lin H, et al. Lipoxin A4 pretreatment mitigates skeletal muscle ischemia-reperfusion injury in rats. Am J Transl Res. 2017;9:1139\u201350.","journal-title":"Am J Transl Res"},{"key":"1885_CR56","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3892\/ijmm.2016.2483","volume":"37","author":"X Jiang","year":"2016","unstructured":"Jiang X, Li Z, Jiang S, et al. Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-kappaB pathway. Int J Mol Med. 2016;37:773\u201380. https:\/\/doi.org\/10.3892\/ijmm.2016.2483.","journal-title":"Int J Mol Med"},{"key":"1885_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02177-19","author":"K Asha","year":"2020","unstructured":"Asha K, Balfe N, Sharma-Walia N. Concurrent control of the kaposi\u2019s sarcoma-associated herpesvirus life cycle through chromatin modulation and host hedgehog signaling: a new prospect for the therapeutic potential of Lipoxin A4. J Virol. 2020. https:\/\/doi.org\/10.1128\/JVI.02177-19.","journal-title":"J Virol"},{"key":"1885_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6815727","author":"L Zong","year":"2016","unstructured":"Zong L, Li J, Chen X, et al. Lipoxin A4 attenuates cell invasion by inhibiting ROS\/ERK\/MMP pathway in pancreatic cancer. Oxid Med Cell Longev. 2016. https:\/\/doi.org\/10.1155\/2016\/6815727.","journal-title":"Oxid Med Cell Longev"},{"issue":"36","key":"1885_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13046-017-0655-5","volume":"2017","author":"L Zong","year":"2017","unstructured":"Zong L, Chen K, Jiang Z, et al. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-beta1 signaling in pancreatic cancer. J Exp Clin Cancer Res. 2017;2017(36):181. https:\/\/doi.org\/10.1186\/s13046-017-0655-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"1885_CR60","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.7150\/jca.32456","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu H, Zeng J, Huang W, et al. Colorectal cancer is associated with a deficiency of Lipoxin A4, an endogenous anti-inflammatory mediator. J Cancer. 2019;10:4719\u201330. https:\/\/doi.org\/10.7150\/jca.32456.","journal-title":"J Cancer"},{"key":"1885_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106341","volume":"144","author":"T Zhang","year":"2019","unstructured":"Zhang T, Hao H, Zhou XY. The role of lipoxin in regulating tumor immune microenvironments. Prostaglandins Other Lipid Mediat. 2019;144: 106341. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106341.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1885_CR62","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.intimp.2019.05.046","volume":"73","author":"Q Wu","year":"2019","unstructured":"Wu Q, Chong L, Shao Y. Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway. Int Immunopharmacol. 2019;73:414\u201323. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.046.","journal-title":"Int Immunopharmacol"},{"key":"1885_CR63","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1007\/s10753-017-0649-7","volume":"40","author":"XQ Chen","year":"2017","unstructured":"Chen XQ, Wu SH, Luo YY, et al. Lipoxin A(4) attenuates bronchopulmonary dysplasia via upregulation of Let-7c and downregulation of TGF-beta(1) signaling pathway. Inflammation. 2017;40:2094\u2013108. https:\/\/doi.org\/10.1007\/s10753-017-0649-7.","journal-title":"Inflammation"},{"key":"1885_CR64","first-page":"6708","volume":"8","author":"YH Sha","year":"2015","unstructured":"Sha YH, Hu YW, Gao JJ, et al. Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells. Int J Clin Exp Pathol. 2015;8:6708\u201315.","journal-title":"Int J Clin Exp Pathol"},{"key":"1885_CR65","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1124\/mol.64.3.721","volume":"64","author":"YS Bae","year":"2003","unstructured":"Bae YS, Park JC, He R, et al. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or Lipoxin A4 in human neutrophils. Mol Pharmacol. 2003;64:721\u201330. https:\/\/doi.org\/10.1124\/mol.64.3.721.","journal-title":"Mol Pharmacol"},{"key":"1885_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pbb.2014.05.023","volume":"124","author":"W Jin","year":"2014","unstructured":"Jin W, Jia Y, Huang L, et al. Lipoxin A4 methyl ester ameliorates cognitive deficits induced by chronic cerebral hypoperfusion through activating ERK\/Nrf2 signaling pathway in rats. Pharmacol Biochem Behav. 2014;124:145\u201352. https:\/\/doi.org\/10.1016\/j.pbb.2014.05.023.","journal-title":"Pharmacol Biochem Behav"},{"key":"1885_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuroscience.2015.04.060","volume":"300","author":"GS Miao","year":"2015","unstructured":"Miao GS, Liu ZH, Wei SX, et al. Lipoxin A4 attenuates radicular pain possibly by inhibiting spinal ERK, JNK and NF-kappaB\/p65 and cytokine signals, but not p38, in a rat model of non-compressive lumbar disc herniation. Neuroscience. 2015;300:10\u20138. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.04.060.","journal-title":"Neuroscience"},{"key":"1885_CR68","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/mi.2016.33","volume":"10","author":"RR Hodges","year":"2017","unstructured":"Hodges RR, Li D, Shatos MA, et al. Lipoxin A(4) activates ALX\/FPR2 receptor to regulate conjunctival goblet cell secretion. Mucosal Immunol. 2017;10:46\u201357. https:\/\/doi.org\/10.1038\/mi.2016.33.","journal-title":"Mucosal Immunol"},{"key":"1885_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089742","volume":"9","author":"R Kumar","year":"2014","unstructured":"Kumar R, Clerc AC, Gori I, et al. Lipoxin A(4) prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E(2) production and estrogen signaling. PLoS ONE. 2014;9: e89742. https:\/\/doi.org\/10.1371\/journal.pone.0089742.","journal-title":"PLoS ONE"},{"key":"1885_CR70","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bbrc.2019.06.137","volume":"516","author":"Z Lu","year":"2019","unstructured":"Lu Z, Zhang H, Zhang X, et al. Lipoxin A4 delays the progression of retinal degeneration via the inhibition of microglial overactivation. Biochem Biophys Res Commun. 2019;516:900\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1885_CR71","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2017101112","volume":"29","author":"EP Brennan","year":"2019","unstructured":"Brennan EP, Mohan M, McClelland A, et al. Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease. J Am Soc Nephrol. 2019;29:1437\u201348. https:\/\/doi.org\/10.1681\/ASN.2017101112.","journal-title":"J Am Soc Nephrol"},{"key":"1885_CR72","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.12659\/MSM.914860","volume":"25","author":"Y Bai","year":"2019","unstructured":"Bai Y, Wang J, He Z, et al. Mesenchymal stem cells reverse diabetic nephropathy disease via Lipoxin A4 by targeting transforming growth factor beta (TGF-beta)\/smad pathway and pro-inflammatory cytokines. Med Sci Monit. 2019;25:3069\u201376. https:\/\/doi.org\/10.12659\/MSM.914860.","journal-title":"Med Sci Monit"},{"key":"1885_CR73","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.intimp.2016.07.026","volume":"39","author":"Q Cheng","year":"2016","unstructured":"Cheng Q, Wang Z, Ma R, et al. Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation. Int Immunopharmacol. 2016;39:229\u201335. https:\/\/doi.org\/10.1016\/j.intimp.2016.07.026.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1885_CR74","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000371490","volume":"51","author":"CF Wenceslau","year":"2014","unstructured":"Wenceslau CF, McCarthy CG, Szasz T, et al. Lipoxin A4 mediates aortic contraction via RHOA\/RHO kinase, endothelial dysfunction and reactive oxygen species. J Vasc Res. 2014;51(6):407\u201317. https:\/\/doi.org\/10.1159\/000371490.","journal-title":"J Vasc Res"},{"key":"1885_CR75","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1096\/fj.06-5809com","volume":"20","author":"K Wada","year":"2006","unstructured":"Wada K, Arita M, Nakajima A, et al. Leukotriene B4 and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation. FASEB J. 2006;20:1785\u201392. https:\/\/doi.org\/10.1096\/fj.06-5809com.","journal-title":"FASEB J"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01885-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01885-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01885-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T17:02:32Z","timestamp":1719680552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01885-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01885-6","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"3 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}